)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Swedish Orphan Biovitrum
Swedish Orphan Biovitrum (SOBI) investor relations material
Swedish Orphan Biovitrum 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary13 Jan, 2026
Strategic growth and portfolio evolution
Strategic portfolio now represents 64% of total business, driven by 39% growth in Q3 and strong performance across all regions.
Acquisition of Arthrosi, a next-generation URAT1 inhibitor for gout, is expected to be highly accretive with a long patent life, supporting growth into the 2030s.
Six major product launches are planned, including Altuviiio, Gamifant (secondary HLH), C3G/IC-MPGN, NASP, Tryngolza, and MCS, with launches spanning 2024 to 2028.
Altuviiio has achieved over 60% market share in early launch countries, with most new patients switching from competitors.
Tryngolza launch preparation targets both rare and broader indications, leveraging strong clinical data and a dedicated internal team.
Pipeline and development highlights
Gamifant showed strong signals in phase II-A for interferon gamma-driven sepsis, with significant unmet need and high mortality rates.
Regulatory milestones expected for C3G/IC-MPGN and Gamifant in Japan and Europe, with key data publications and decisions anticipated in 2024.
Zynlonta's LOTIS-5 trial data readout is expected in H1 2024, and the Arthrosi transaction is targeted to close in Q1.
Capital Markets Day scheduled for February 18 to provide further strategic orientation and discuss economic outlook.
Financial and market outlook
Beyfortus remains a stable and growing earnings stream, with strong physician and reimbursement support despite public debate on RSV prevention.
Increasing royalty rates for Beyfortus through 2028 help offset competitive risks, supporting investment in new growth opportunities.
Optimism for sustained growth is underpinned by a robust late-stage pipeline, multiple launches, and strategic acquisitions.
Arthrosi: Pre-Phase III acquisition confidence
Tryngolza: Scaling for 1M patient market
Gamifant sepsis: Regulatory consultation timeline
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Swedish Orphan Biovitrum earnings date
Q4 20255 Feb, 2026
Swedish Orphan Biovitrum
Next Swedish Orphan Biovitrum earnings date
Q4 20255 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Swedish Orphan Biovitrum AB, an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. The company operates through three segments: Haemophilia & Hereditary Diseases, Inflammation & Immunology, and Other. It offers Alprolix for hemophilia B; Elocta to treat hemophilia A; Doptelet for thrombocytopenia; Kineret for rheumatoid arthritis; Thiola for cystinuria; Xultophy Cartridge that is used with Flexpen for treatment of diabetes; and Velphoro for hyperphosphatemia.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage